Prospective cohort study of compliance with faecal immunochemical tests for colorectal cancer screening in Hong Kong

Preventive Medicine

Volumn 57, Issue 3, 2013, Pages 227-231

  Wong, Martin C S ^a,b   Ching, Jessica Y L ^a   Lam, Thomas Y T ^a   Luk, Arthur K C ^a   Hirai, Hoyee W ^a   Griffiths, Sian M ^b   Chan, Francis K L ^a   Sung, Joseph J Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Colorectal cancer; Compliance; Determinants; Faecal occult blood; Screening

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; FAMILY HISTORY; FECES ANALYSIS; FEMALE; FOLLOW UP; HONG KONG; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTOCOL COMPLIANCE;

ADJUSTED ODDS RATIOS; AOR; COLORECTAL CANCER; COMPLIANCE; CRC; DETERMINANTS; FAECAL IMMUNOCHEMICAL TESTS; FAECAL OCCULT BLOOD; FAECAL OCCULT BLOOD TESTS; FIT; FOBT; SCREENING;

AGE FACTORS; AGED; COLORECTAL NEOPLASMS; FEMALE; HONG KONG; HUMANS; IMMUNOLOGIC TESTS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS;

EID: 84881615068     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2013.05.017     Document Type: Article

References (37)

1. Advisory Committee on Cancer Prevention Recommendations on cancer screening in the European Union. Eur. J. Cancer 2000, 36:1473-1478.
2. Barratt A., Mannes P., Irwig L., Trevena L., Craig J., Rychetnik L. Cancer screening. J. Epidemiol. Community Health 2002, 56:899-902.
3. Brenner H., Hoffmeister M., Brenner G., Altenhofen L., Haug U. Expected reduction of colorectal cancer incidence within 8years after introduction of the German screening colonoscopy programme: estimates based on 1,875,708 screening colonoscopies. Eur. J. Cancer 2009, 45:2027-2033.
4. Champion V., Skinner C.S. The health belief model. Health Behavior and Health Education: Theory, Research and Practice 2008, 45-65. Jossey-Bass, San Francisco, Calif, USA. 4th edition. K. Glanz, B.K. Rimer, K. Wisnanath (Eds.).
5. Courtier R., Casamitjana M., Macià F., et al. Participation in a colorectal cancer screening programme: influence of the method of contacting the target population. Eur. J. Cancer Prev. 2002, 11:209-213.
6. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2010, 127:2893-2917.
7. Gimeno García A.Z. Factors influencing colorectal cancer screening participation. Gastroenterol. Res. Pract. 2012, 2012:483417.
8. Glanz K., Bishop D.B. The role of behavioral science theory in development and implementation of public health interventions. Annu. Rev. Public Health 2010, 31:399-418.
9. Goulard H., Boussac-Zarebska M., Ancelle-Park R., et al. Evaluation epidemiologique du depistage du cancer du colon et du rectum. Premieres campagnes du programme pilote francais, 2007 2007, (http://www.invs.sante.fr/publications/2007/cancer_colon_rectum/cancer_colon_rectum.pdf (accessed 11 January 2013).
10. Hardcastle J.D., Chamberlain J.O., Robinson M.H., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996, 348:1472-1477.
11. Hewitson P., Glasziou P., Irwig L., Towler B., Watson E. Screening for colorectal cancer using the faecal occult blood test, hemoccult. Cochrane Database Syst. Rev. 2007, 24:CD001216.
12. Hsia J., Kemper E., Kiefe C., et al. The importance of health insurance as a determinant of cancer screening: evidence from the women's health initiative. Prev. Med. 2000, 31:261-270.
13. Ioannou G.N., Chapko M.K., Dominitz J.A. Predictors of colorectal cancer screening participation in the United States. Am. J. Gastroenterol. 2003, 98:2082-2091.
14. Jørgensen O.D., Kronborg O., Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13years and seven biennial screening rounds. Gut 2002, 50:29-32.
15. Lairson D.R., Chang Y.C., Bettencourt J.L., Vernon S.W., Greisinger A. Estimating development cost for a tailored interactive computer program to enhance colorectal cancer screening compliance. J. Am. Med. Inform. Assoc. 2006, 13:476-484.
16. Levin B., Lieberman A.D., McFarland B., et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the U.S. Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J. Clin. 2008, 58:130-160.
17. Mandel J.S., Church T.R., Ederer F., et al. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J. Natl. Cancer Inst. 1999, 91:434-437.
18. McCaffery K., Wardle J., Waller J. Knowledge, attitudes, and behavioral intentions in relation to the early detection of colorectal cancer in the United Kingdom. Prev. Med. 2003, 36:525-535.
19. Moss S.M., Campbell C., Melia J., et al. Performance measures in three rounds of the English bowel cancer screening pilot. Gut 2012, 61:101-107.
20. Myers R.E., Ross E., Jepson C., et al. Modeling adherence to colorectal cancer screening. Prev. Med. 1994, 23:142-151.
21. Parente F., Marino B., DeVecchi N., Moretti R. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer. Br. J. Surg. 2009, 96:533-540.
22. Pignone M., Rich M., Teutsch S.M., Berg A.O., Lohr K.N. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann. Intern. Med. 2002, 137:132-141.
23. Pornet C., Dejardin O., Morlais F., Bouvier V., Launoy G. Socioeconomic determinants for compliance to colorectal cancer screening. A multilevel analysis. J. Epidemiol. Community Health 2010, 64:318-324.
24. Saito H. Colorectal cancer screening using immunochemical faecal occult blood testing in Japan. J. Med. Screen. 2006, 13:S6-S7.
25. Subramanian S., Klosterman M., Amonkar M.M., Hunt T.L. Adherence with colorectal cancer screening guidelines: a review. Prev. Med. 2004, 38:536-550.
26. Subramanian S., Bobashev G., Morris R.J. Modeling the cost-effectiveness of colorectal cancer screening: policy guidance based on patient preferences and compliance. Cancer Epidemiol. Biomarkers Prev. 2009, 18:1971-1978.
27. Sung J.J.Y., Lau J.Y.W., Goh K.L., Leung W.K. for the on Asia Pacific Working Group on Colorectal Cancer. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 2005, 6:871-876.
28. Sung J.J., Lau J.Y., Young G.P., et al. Asia Pacific consensus recommendations for colorectal cancer screening. Gut 2008, 57:1166-1176.
29. Sung J.J., Choi S.Y., Chan F.K., Ching J.Y., Lau J.T., Griffiths S. Obstacles to colorectal cancer screening in Chinese: a study based on the health belief model. Am. J. Gastroenterol. 2008, 103:974-981.
30. Szczepura A., Price C., Gumber A. Breast and bowel cancer screening uptake patterns over 15years for UK south Asian ethnic minority populations, corrected for differences in socio-demographic characteristics. BMC Public Health 2008, 2:346.
31. Thrasher J.F., Cummings K.M., Michalek A.M., Mahoney M.C., Moysich K.B., Pillittere D.M. Colorectal cancer screening among individuals with and without a family history. J. Public Health Manag. Pract. 2002, 8:1-9.
32. von Euler-Chelpin M., Brasso K., Lynge E. Determinants of participation in colorectal cancer screening with faecal occult blood testing. J. Public Health (Oxf.) 2010, 32:395-405.
33. Weller D., Coleman D., Robertson R., et al. The UK colorectal cancer screening pilot: results of the second round of screening in England. Br. J. Cancer 2007, 97:1601-1605.
34. Wong M.C., Tsoi K.K., Ng S.S., et al. A comparison of the acceptance of immunochemical faecal occult blood test and colonoscopy in colorectal cancer screening: a prospective study among Chinese. Aliment. Pharmacol. Ther. 2010, 32:74-82.
35. Wong C.K., Lam C.L., Poon J.T., et al. Direct medical costs of care for Chinese patients with colorectal neoplasia: a health care service provider perspective. J. Eval. Clin. Pract. 2012, 18:1203-1210.
36. Young G.P., St John J.B., Winawer S.J., Rozen P. Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies; a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy). Am. J. Gastroenterol. 2002, 97:2499-2507.
37. Zorzi M., Barca A., Falcini F., et al. Screening for colorectal cancer in Italy: 2005 survey. Epidemiol. Prev. 2007, 31:49-60.